A Conversation With Dr. DiLeo (Fedorchak)
Dr. DiLeo is an Early Stage Investigator (ESI) interested in the study of translational materials, particularly for controlled release therapeutics. Her laboratory focuses on the design and testing of various drug delivery systems and regenerative biomaterials, with an emphasis on ophthalmic applications. Morgan has trained in biomaterials fabrication, including surface conjugation and imaging, and rational design of controlled release systems. Morgan's primary goal is to use her interdisciplinary experience and network of clinicians, basic scientists, and engineers to perform translational research in novel therapeutics. In particular, her focus has been on bridging the gap between the clinical needs of patients and the engineering capabilities inherent to various biomaterials in order to expedite translation. Dr. DiLeo group does this by using a "bedside-to-bench-to-bedside" approach in close collaboration with clinicians to maximize the translatability of the experiments performed in her lab. Another focus area is the professional development of graduate students and postdoctoral researchers to enhance their technical skillset and advance their careers. Morgan regularly engages in numerous mentorship activities, and proactively seek out opportunities to improve the training environment in her lab.
2013—Research Assistant Professor, Chemical Engineering
2015—Assistant Professor, Ophthalmology
2015 - Present, ChE/BioE 1533, Controlled Drug Delivery, University of Pittsburgh
Education & Training
- Carnegie Mellon University, Pittsburgh, PA, Chemical and Biomedical Engineering, B.S.
- University of Pittsburgh, Pittsburgh, PA, Bioengineering, Ph.D.
Dr. DiLeo research interests include drug delivery to the eye and the development of novel biomaterials for ophthalmic applications.